Science Group plc Finalizes Share Buyback, Acquires 5,000 Shares at 587p Each

Details on Share Buyback Execution and Pricing

On 24 July 2026, Science Group plc purchased 5,000 ordinary shares at a consistent price of 587 pence per share through Panmure Liberum Limited, the company’s nominated adviser and joint broker. The transaction was executed on the AIM exchange (AIMX) at 10:19:13. The uniform pricing across the entire purchase indicates a single consolidated trade, reflecting an orderly execution within the buyback programme.

The 587 pence per share price reflects management’s decision on capital deployment for share repurchases. The buyback was conducted in line with the company’s authorised share buyback authority and regulatory requirements for transactions involving own shares. Full disclosure of the purchase details, including execution venue, timing, and pricing, complies with Article 5(1)(b) of Regulation (EU) No 596/2014 (Market Abuse Regulation), ensuring transparency for market participants.

Treasury Shares and Capital Structure Post-Purchase

Following this acquisition, Science Group’s capital structure now includes 5,538,281 shares held in treasury. These shares, previously issued, are retained by the company rather than cancelled, providing flexibility in capital management. Treasury shares can be cancelled, reissued through employee share schemes, or used for acquisitions without requiring new shareholder approval for each issuance.

The total ordinary shares in issue, excluding treasury shares, stand at 40,647,593 after this transaction. This figure is critical for shareholders when calculating notification thresholds under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules. The distinction between issued shares and those in circulation affects voting rights and regulatory notifications.

Minimal Impact on Voting Rights and Dilution Considerations

The 5,000 shares repurchased represent just 0.01% of voting rights prior to the buyback, indicating a cautious approach with negligible effect on voting power distribution among shareholders. Although this transaction is small, cumulative buybacks over time can reduce share count significantly and improve earnings per share (EPS), especially when executed at valuations deemed favorable by the board.

From a dilution standpoint, the buyback reflects a strategic capital allocation to return value to shareholders. By repurchasing shares at 587 pence, the company reduces shares eligible for dividends and other distributions, potentially enhancing per-share returns. This strategy assumes the repurchase price offers appropriate value compared to alternative uses of capital such as reinvestment or acquisitions.

Compliance with Regulatory and Market Abuse Rules

Science Group has disclosed comprehensive details of the share purchase in accordance with the Market Abuse Regulation, which mandates transparency for buyback transactions. The announcement includes the number of shares bought, transaction price, exact timing, and execution venue, fulfilling EU Regulation 596/2014 requirements. This ensures all investors have equal access to information about the company’s buyback activities.

Utilizing Panmure Liberum Limited as the executing broker adds governance oversight, as the nominated adviser ensures compliance with company policies and regulatory standards. Execution on the AIM exchange’s regulated platform further confirms transparency and adherence to Listing Rules and internal share buyback policies.

Overview of Science Group’s Operations and Market Status

Science Group plc is a multi-disciplinary scientific and engineering consulting firm serving diverse sectors with technical expertise. Listed on the AIM market under ticker SAG, it operates as a growth-oriented company. Its business model centers on delivering consulting services and project work across engineering and scientific disciplines.

As an AIM-listed entity, Science Group benefits from flexible regulatory requirements suited to smaller or growth-stage companies. The decision to repurchase shares at current prices signals management’s confidence in the company’s strategic outlook and valuation, preferring buybacks over alternatives like acquisitions, debt reduction, or operational investments.

Context of the Share Buyback Programme and Capital Allocation

Share buyback programmes are formal capital allocation strategies allowing companies to return value by repurchasing shares on the open market. Science Group’s recent purchase forms part of an ongoing programme authorized by shareholders through board resolutions or votes. The 5,000-share transaction demonstrates exercise of this authority at market levels deemed attractive by management.

The modest volume and single execution suggest an opportunistic buyback approach rather than continuous repurchases. This flexibility enables management to respond to market conditions and share price movements, executing purchases when valuations are favorable. Continued buybacks over time would indicate sustained capital deployment aligned with the company’s broader capital strategy.

Management of Treasury Shares and Future Capital Flexibility

By retaining shares in treasury instead of cancelling them, Science Group maintains flexibility in capital structure management. Treasury shares can be cancelled later to reduce share count permanently or reissued for capital raising or employee compensation without immediate shareholder approval.

The current treasury holding of 5,538,281 shares represents a significant equity reserve for future corporate actions. This approach balances short-term shareholder benefits from reduced share counts with long-term strategic options for capital management and growth.

Shareholder Notification and FCA Disclosure Compliance

Science Group specifies that shareholders should use the figure of 40,647,593 ordinary shares in issue (excluding treasury) as the denominator for calculating notification thresholds under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules. These rules require shareholders to disclose interests when crossing specified voting rights percentages, ensuring market transparency.

Providing this precise denominator helps shareholders accurately determine their notification obligations, supporting regulatory compliance and investor protection. These transparency measures uphold market integrity by informing investors about significant ownership changes.

Impact on Earnings Per Share and Shareholder Value

Reducing the share count through buybacks can mechanically enhance earnings per share (EPS) by distributing earnings over fewer shares, assuming net income remains stable. This effect is more pronounced when shares are repurchased at prices management considers below intrinsic value.

Value creation depends on the repurchase price relative to intrinsic value. Buying shares below intrinsic value benefits remaining shareholders by concentrating earnings, while repurchasing above intrinsic value can erode shareholder value. The board’s decision to buy at 587 pence reflects their view of fair value, though ultimate benefits depend on future earnings and share price performance.